BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15882270)

  • 1. The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice.
    Ivanovski O; Szumilak D; Nguyen-Khoa T; Ruellan N; Phan O; Lacour B; Descamps-Latscha B; Drüeke TB; Massy ZA
    Kidney Int; 2005 Jun; 67(6):2288-94. PubMed ID: 15882270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
    Massy ZA; Ivanovski O; Nguyen-Khoa T; Angulo J; Szumilak D; Mothu N; Phan O; Daudon M; Lacour B; Drüeke TB; Muntzel MS
    J Am Soc Nephrol; 2005 Jan; 16(1):109-16. PubMed ID: 15563564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerosis and vascular calcification in uraemia - a new experimental model.
    Ivanovski O; Nikolov IG; Drueke BT; Massy AZ
    Prilozi; 2007 Dec; 28(2):11-24. PubMed ID: 18356775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiatherogenic effect of pioglitazone on uremic apolipoprotein E knockout mice by modulation of the balance of regulatory and effector T cells.
    Shen Y; Yuan Z; Yin A; Liu Y; Xiao Y; Wu Y; Wang L; Liang X; Zhao Y; Tian Y; Liu W; Chen T; Kishimoto C
    Atherosclerosis; 2011 Oct; 218(2):330-8. PubMed ID: 21868013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice.
    Phan O; Ivanovski O; Nguyen-Khoa T; Mothu N; Angulo J; Westenfeld R; Ketteler M; Meert N; Maizel J; Nikolov IG; Vanholder R; Lacour B; Drüeke TB; Massy ZA
    Circulation; 2005 Nov; 112(18):2875-82. PubMed ID: 16267260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of uremia in apolipoprotein E-deficient mice.
    Bro S
    Dan Med Bull; 2009 Nov; 56(4):177-92. PubMed ID: 19939336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice.
    Bro S; Bentzon JF; Falk E; Andersen CB; Olgaard K; Nielsen LB
    J Am Soc Nephrol; 2003 Oct; 14(10):2466-74. PubMed ID: 14514724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcification of the cavernosal bodies may be responsible for development of erectile dysfunction in uremic apolipoprotein E deficient (apoE-/-) mice.
    Ivanovski O; Nikolov IG; Davceva O; Petrushevska G
    Rev Int Androl; 2021; 19(1):25-33. PubMed ID: 31899189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein-E deficient mice.
    Pedersen TX; Bro S; Andersen MH; Etzerodt M; Jauhiainen M; Moestrup S; Nielsen LB
    Atherosclerosis; 2009 Feb; 202(2):372-81. PubMed ID: 18489910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antioxidant N-acetylcysteine promotes atherosclerotic plaque stabilization through suppression of RAGE, MMPs and NF-κB in ApoE-deficient mice.
    Lu Y; Qin W; Shen T; Dou L; Man Y; Wang S; Xiao C; Li J
    J Atheroscler Thromb; 2011; 18(11):998-1008. PubMed ID: 21873804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The apolipoprotein e knockout mouse: a model documenting accelerated atherogenesis in uremia.
    Buzello M; Törnig J; Faulhaber J; Ehmke H; Ritz E; Amann K
    J Am Soc Nephrol; 2003 Feb; 14(2):311-6. PubMed ID: 12538731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice.
    Bro S; Borup R; Andersen CB; Moeller F; Olgaard K; Nielsen LB
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):570-5. PubMed ID: 16373611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farnesyltransferase inhibitor R115777 protects against vascular disease in uremic mice.
    Nikolov IG; Joki N; Galmiche A; Nguyen-Khoa T; Guerrera IC; Guillonneau F; Ivanovski O; Phan O; Maizel J; Marçon F; Benchitrit J; Lucas A; Edelman A; Lacour B; Drüeke TB; Massy ZA
    Atherosclerosis; 2013 Jul; 229(1):42-51. PubMed ID: 23672878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice.
    Ivanovski O; Nikolov IG; Joki N; Caudrillier A; Phan O; Mentaverri R; Maizel J; Hamada Y; Nguyen-Khoa T; Fukagawa M; Kamel S; Lacour B; Drüeke TB; Massy ZA
    Atherosclerosis; 2009 Jul; 205(1):55-62. PubMed ID: 19118829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-E-deficient mice.
    Bro S; Moeller F; Andersen CB; Olgaard K; Nielsen LB
    J Am Soc Nephrol; 2004 Jun; 15(6):1495-503. PubMed ID: 15153560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice.
    Nikolov IG; Joki N; Nguyen-Khoa T; Guerrera IC; Maizel J; Benchitrit J; Machado dos Reis L; Edelman A; Lacour B; Jorgetti V; Drüeke TB; Massy ZA
    Nephrol Dial Transplant; 2012 Feb; 27(2):505-13. PubMed ID: 21705467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of klotho gene in uremic atherosclerosis in apolipoprotein E-deficient mice.
    Yu J; Deng M; Zhao J; Huang L
    Biochem Biophys Res Commun; 2010 Jan; 391(1):261-6. PubMed ID: 19912987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice.
    Candido R; Jandeleit-Dahm KA; Cao Z; Nesteroff SP; Burns WC; Twigg SM; Dilley RJ; Cooper ME; Allen TJ
    Circulation; 2002 Jul; 106(2):246-53. PubMed ID: 12105166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of simvastatin in apolipoprotein E deficient mice with surgically induced chronic renal failure.
    Ivanovski O; Szumilak D; Nguyen-Khoa T; Nikolov IG; Joki N; Mothu N; Maizel J; Westenfeld R; Ketteler M; Lacour B; Drüeke TB; Massy ZA
    J Urol; 2008 Apr; 179(4):1631-6. PubMed ID: 18295249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice.
    Park TS; Rosebury W; Kindt EK; Kowala MC; Panek RL
    Pharmacol Res; 2008 Jul; 58(1):45-51. PubMed ID: 18611440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.